Normal insulin release during sustained hyperglycaemia in hypokalaemic periodic paralysis: Role of the potassium channel opener pinacidil in impaired muscle strength

Clinical Science

Volumn 91, Issue 5, 1996, Pages 583-589

  Ligtenberg, J J M ^a   Van Haeften, T W ^b   Van Der Kolk, L E ^a   Smit, A J ^a   Sluiter, W J ^a   Reitsma, W D ^b   Links, T P ^a  

^a UNIVERSITY MEDICAL CENTER GRONINGEN   (Netherlands)

^b UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

Author keywords

Hyperglycaemia; Hypokalaemic periodic paralysis; Insulin release; Muscle strength; Pinacidil

Indexed keywords

GLUCOSE; INSULIN; PINACIDIL; POTASSIUM CHANNEL; POTASSIUM CHANNEL STIMULATING AGENT;

ADULT; AREA UNDER THE CURVE; ARTICLE; CASE REPORT; CLINICAL PROTOCOL; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; FEMALE; GLUCOSE BLOOD LEVEL; HIP; HUMAN; HYPERGLYCEMIA; HYPOKALEMIC PERIODIC PARALYSIS; INSULIN BLOOD LEVEL; INSULIN RELEASE; INSULIN SENSITIVITY; MALE; MUSCLE STRENGTH; MUSCLE WEAKNESS; ORAL DRUG ADMINISTRATION; PERIODIC PARALYSIS; POTASSIUM BLOOD LEVEL; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL;

EID: 0029960446     PISSN: 01435221     EISSN: None     Source Type: Journal    
DOI: 10.1042/cs0910583     Document Type: Article

References (34)

1. Engel AG. Periodic paralysis. In: Engel AG, Banker BQ, eds. Myology. basic and clinical. New York: McGraw-Hill, 1986: 1843-70.
2. Links TP. Smit AJ, Molenaar WM, Zwarts MJ, Oosterhuis HJ. Familial hypokalemic periodic paralysis. Clinical, diagnostic and therapeutic aspects. J Neurol Sei 1994; 122: 33-43.
3. Sipos I, Jurkat-Rott K, Harasitosi C, et al. Skeletal muscle DHP receptor mutations alter calcium currents in human hypokaJaemic periodic paralysis myotubes. J Phystol (London) 1995; 483:299-306.
4. Johnsen T, Houston ME, Saltin B. Skeletal muscle characteristics and carbohydrate metabolism after glucose loading in hypokalaemic periodic paralysis. Scand J Clin Lab Invest 1978; 38:549-56.
5. Johnsen T, Beck-Nielsen H. Insulin receptors, insulin secretion, and glucose disappearance rate in patients with periodic hypokalaemic paralysis. Acta Endocrinol 1979;90:272-82.
6. Johnsen T. Effect upon serum insulin, glucose and potassium concentrations of acetazolamide during attacks of familial periodic hypokalemic paralysis. Acta Neural Scand 1977; 56:533-41.
7. Griggs RC, Resnick J, Engel WK. Intravenous treatment of hypokatemic periodic paralysis. Arch Neurol 1983; 40:539-40.
8. Minaker KL, Meneilly GS, Flier JS, Rowe JW. Insulin-mediated hypokalemia and paralysis in familial hypokalemic periodic paralysis. Am J Med 1988; 84: 1001-6.
9. Links TP, Smit AJ, Oosterhuis HJ, Reitsma WD. Potassium channels in hypokalaemic periodic paralysis: a key to the pathogenesis? din Sei 1993; 85: 319-25.
10. Cook NS. The pharmacology of potassium channels and their therapeutic potential. Trends Pharmacol Sei 1988; 9:21-8.
11. Hermsmeyer RK. Pinacidil actions on ion channels in vascular muscle. J Cardiovasc Pharmacol 1988; 12 (Suppl. 2): 17-22.
12. + conductance improves in vitro the contraction force of skeletal muscle in hypokalemic periodic paralysis. Muscle Nerve 1990; 13:451-7.
13. Quasthoff S, Franke C, Hatt H, Rkhter-Turtur M. Two different types of potassium channels in human skeletal muscle activated by potassium channel openers. Neurosci Lett 1990; 119: 191-4.
14. Rajan AS, Aguilar-Bryan U Nelson DA, et al. Ion channels and insulin secretion. Diabetes Care 1990; 13:340-63.
15. + channels by calcium. Diabetes 1990; 39:1457-60.
16. Garrino MG, Plant TD, Henquin JC. Effects of putative activators of potassium channels in mouse pancreatic B-cells. Br J Pharmacol 1989; 98:957-65.
17. + outflow from pancreatic B-cells. Eur J Pharmacol 1988; 156: 283-6.
18. Links TP, Smit AJ, Reitsma WD. Potassium channel modulation: effect of pinacidil on insulin release in healthy volunteers. J Clin Pharmacol 1995; 35:291 -4.
19. Van Haeften TW, Boonstra E, Veneman TF, Gerich JE, Van der Veen EA. Dose-response characteristics for glucose-stimulated insulin release in man and the assessment of influence of glucose on arginine stimulated insulin release. Metabolism 1990; 39:1292-9.
20. DeFronzo RA, Tobin JD, Andres R. Glucose clamp technique: a method for quantifying insulin secretion and resistance. Am J Physiol 1979; 237: E214-23.
21. Van der Ploeg RJ, Fidter V, Oosterhuis HJ. Hand-held myometry: reference values. J Neurol Neurosurg Psychiatry 1991; 54:244-7.
22. Mitrakou A, Vuorinen-Markkola H, Raptis G, et al. Simultaneous assessment of insulin secretion and insulin sensitivity using a hyperglycemic damp. J Gin Endocrinol Metab 1992; 75:379-81
23. + channel opener pinacidil. J Neurol Sei 1990; 98 (Suppl. 379).
24. Aguilar-Brvan L, Nichols CG, Wechsler SW, et al. Cloning of the B cell high-affinity sutfonylurea receptor: a regulator of insulin secretion. Science (Washington DC) 1995; 268: 423-6.
25. Smith CPG. Between and within subject variation of the first phase insulin response to intravenous glucose. Diabetotogia 1988; 31:123-5.
26. Groop LC. Insulin resistance and insulin deficiency in the pathogenesis of type 2 (non-insulin-dependent) diabetes mellitus: errors of metabolism or of methods? Diabetotogia 1993; 36: 1326-31.
27. Liu D. Moberg E, Kollind M, Lins P, Adamson U, Macdonald IA. Arterial, arterialized venous, venous and capillary Hood glucose measurements in normal man during hyperinsulinaemic euglycemia and hypoglycemia. Diabetotogia 1992; 35:287-90.
28. Links TP, Smit AJ, Reitsma WD: Potassium channel modulation: effect of pinacidil and glibenclamide on insulin release in healthy volunteers. In: Familial hypokatemic periodic paralysis (Thesis). Haren. The Netherlands: Niemeijer, 1992; 123-30.
29. Ligtenberg JJM, Leenaers AD, Van Haeften TW. Smit AJ, Sluiter WJ, Reitsma WD. No deterioration of insulin secretion by the potassium channel opener pinacidil in essential hypertension, j Human Hypertension 1996; 10:269-76.
30. Friedel AF, Brogden RN. Pinacidil. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic potential in the treatment of hypertension. Drugs 1990; 39:929-67.
31. Links TP, Zwarts MJ, Wilmink JT. Molenaar WM. Oosterhuis HJ. Permanent muscle weakness in familial hypokalaemk: periodic paralysis. Clinical, radiological and pathological aspects. Brain 1990; 113: 1873-89.
32. + conductance in human skeletal muscle fibres. Pflugers Arch 1989;414(Suppl I): 179-80.
33. + channel openers suppress myotonic activity of human skeletal muscle in vitro. Eur J Pharmacol 1990; 186: 125-8.
34. Rudel R, Lehmann-Hom F, Rider K, Kuther G. Hypokatemic periodic paralysis: in vitro investigation of muscle fiber membrane parameters. Muscle Nerve 1984; 7:110-20.